Supernus Pharmaceuticals
SUPN
#4394
Rank
โ‚ฌ1.58 B
Marketcap
28,34ย โ‚ฌ
Share price
2.78%
Change (1 day)
3.46%
Change (1 year)

Revenue for Supernus Pharmaceuticals (SUPN)

Revenue in 2024 (TTM): โ‚ฌ0.61 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.58 Billion. an increase over the revenue in the year 2023 that were of โ‚ฌ0.54 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Supernus Pharmaceuticals from 2011 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ0.63 B15.73%
2023 โ‚ฌ0.54 B-11.65%
2022 โ‚ฌ0.62 B21.5%
2021 โ‚ฌ0.51 B21%
2020 โ‚ฌ0.42 B20.68%
2019 โ‚ฌ0.35 B-1.91%
2018 โ‚ฌ0.35 B41.9%
2017 โ‚ฌ0.25 B23.23%
2016 โ‚ฌ0.20 B52.63%
2015 โ‚ฌ0.13 B76.58%
2014 โ‚ฌ75.84 M771.41%
2013 โ‚ฌ8.7 M678.44%
2012 โ‚ฌ1.11 M-115.98%
2011 -โ‚ฌ7 Million

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ71.85 M-87.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.53 B 334.77%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ39.61 B 6,705.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ42.48 B 7,198.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ36.89 B 6,238.61%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ78.12 B 13,320.78%๐Ÿ‡บ๐Ÿ‡ธ USA